BSE Circulars (17638)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces listing and admission for trading of further securities issued under ESOP/ESOS schemes by Genus Power, Ivalue Infosolutions, … | |||||||||||||||
BSE announces listing and admission for trading of further securities issued under ESOP/ESOS schemes by Genus Power, Ivalue Infosolutions, Kirloskar Industries, and UTI AMC, effective January 01, 2026.
| |||||||||||||||
BSE announces listing of additional shares issued by four companies under employee stock option schemes, effective January 1, 2026. | |||||||||||||||
BSE announces listing of additional shares issued by four companies under employee stock option schemes, effective January 1, 2026.
| |||||||||||||||
Listing and trading permission for 16,61,000 equity shares issued on preferential basis pursuant to conversion of warrants, effective … | |||||||||||||||
Listing and trading permission for 16,61,000 equity shares issued on preferential basis pursuant to conversion of warrants, effective January 1, 2026.
| |||||||||||||||
16,61,000 new equity shares of NOVELIX PHARMACEUTICALS LIMITED listed on BSE effective January 1, 2026, issued through preferential … | |||||||||||||||
16,61,000 new equity shares of NOVELIX PHARMACEUTICALS LIMITED listed on BSE effective January 1, 2026, issued through preferential allotment via warrant conversion.
| |||||||||||||||
16,61,000 equity shares of Novelix Pharmaceuticals Limited listed on BSE effective January 1, 2026, issued through preferential allotment … | |||||||||||||||
16,61,000 equity shares of Novelix Pharmaceuticals Limited listed on BSE effective January 1, 2026, issued through preferential allotment via warrant conversion.
| |||||||||||||||
16,61,000 equity shares of Novelix Pharmaceuticals Limited listed on BSE with effect from January 1, 2026, issued on preferential basis … | |||||||||||||||
16,61,000 equity shares of Novelix Pharmaceuticals Limited listed on BSE with effect from January 1, 2026, issued on preferential basis pursuant to warrant conversion.
| |||||||||||||||
BSE announces the listing of privately placed debt securities of Shriram Life Insurance Company Limited with INE227H08011 ISIN, effective … | |||||||||||||||
BSE announces the listing of privately placed debt securities of Shriram Life Insurance Company Limited with INE227H08011 ISIN, effective December 31, 2025.
| |||||||||||||||
Announcement of listing of commercial papers from Capri Global Capital, Reliance Jio Infocomm, Lendingkart Finance, Ashoka Buildcon and debt … | |||||||||||||||
Announcement of listing of commercial papers from Capri Global Capital, Reliance Jio Infocomm, Lendingkart Finance, Ashoka Buildcon and debt securities from Satin Finserv on BSE Debt Segment effective December 31, 2025.
| |||||||||||||||
New privately placed commercial papers and debt securities from multiple companies including Capri Global Capital, Reliance Jio Infocomm, … | |||||||||||||||
New privately placed commercial papers and debt securities from multiple companies including Capri Global Capital, Reliance Jio Infocomm, Lendingkart Finance, Ashoka Buildcon, and Satin Finserv are listed and admitted to trading on BSE Debt Segment.
| |||||||||||||||
BSE announces listing of commercial papers and debt securities from Capri Global Capital, Reliance Jio Infocomm, Lendingkart Finance, Ashoka … | |||||||||||||||
BSE announces listing of commercial papers and debt securities from Capri Global Capital, Reliance Jio Infocomm, Lendingkart Finance, Ashoka Buildcon, and Satin Finserv on the debt segment effective December 31, 2025.
| |||||||||||||||